High levels of extracellular matrix metalloproteinase inducer are expressed in lymphangioleiomyomatosis

Human Pathology

Volumn 41, Issue 7, 2010, Pages 935-943

  Odajima, Nao ^a   Betsuyaku, Tomoko ^a   Yoshida, Takayuki ^a   Hosokawa, Takeshi ^b   Nishimura, Masaharu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

Author keywords

Bronchoalveolar lavage; Immunohistochemistry; Laser capture microdissection

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD147 ANTIGEN; GELATINASE A; GELATINASE B; MESSENGER RNA;

ADULT; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LASER MICRODISSECTION; LUNG HOMOGENATE; LUNG LAVAGE; LYMPHANGIOLEIOMYOMATOSIS; PROTEIN EXPRESSION; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTIGENS, CD147; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; LYMPHANGIOLEIOMYOMATOSIS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RNA, MESSENGER;

EID: 77953287374     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.12.009     Document Type: Article

References (35)

1. Corrin B., Liebow A.A., and Friedman P.J. Pulmonary lymphangiomyomatosis. A review. Am J Pathol 79 (1975) 348-382
2. Ferrans V.J., Yu Z.X., Nelson W.K., et al. Lymphangioleiomyomatosis (LAM). A review of clinical and morphological features. J Nippon Med Sch 67 (2000) 311-329
3. Hayashi T., Fleming M.V., Stetler-Stevenson W.G., et al. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). Hum Pathol 28 (1997) 1071-1078
4. Matsui K., Takeda K., Yu Z.X., Travis W.D., and Ferrans V.J. Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis. Arch Pathol Lab Med 124 (2000) 267-275
5. Odajima N., Betsuyaku T., Nasuhara Y., Inoue H., Seyama K., and Nishimura M. Matrix metalloproteinases in blood from patients with LAM. Respir Med 103 (2009) 124-129
6. Kataoka H., DeCastro R., Zucker S., and Biswas C. Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res 53 (1993) 3154-3158
7. Nabeshima K., Iwasaki H., Koga K., Hojo H., Suzumiya J., and Kikuchi M. Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 56 (2006) 359-367
8. Greenlee K.J., Werb Z., and Kheradmand F. Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev 87 (2007) 69-98
9. Li Y.Y., McTiernan C.F., and Feldman A.M. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 46 (2000) 214-224
10. Shackel N.A., McGuinness P.H., Abbott C.A., Gorrell M.D., and McCaughan G.W. Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. Am J Pathol 160 (2002) 641-654
11. Betsuyaku T., Tanino M., Nagai K., Nasuhara Y., Nishimura M., and Senior R.M. Extracellular matrix metalloproteinase inducer is increased in smokers' bronchoalveolar lavage fluid. Am J Respir Crit Care Med 168 (2003) 222-227
12. Odajima N., Betsuyaku T., Nasuhara Y., et al. Extracellular matrix metalloproteinase inducer in interstitial pneumonias. Hum Pathol 37 (2006) 1058-1065
13. Toole B.P. Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function. Curr Top Dev Biol 54 (2003) 371-389
14. Iacono K.T., Brown A.L., Greene M.I., and Saouaf S.J. CD147 immunoglobulin superfamily receptor function and role in pathology. Exp Mol Pathol 83 (2007) 283-295
15. Karbowniczek M., Astrinidis A., Balsara B.R., et al. Recurrent lymphangiomyomatosis after transplantation genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med 167 (2003) 976-982
16. Henske E.P. Metastasis of benign tumor cells in tuberous sclerosis complex. Genes Chromosomes Cancer 38 (2003) 376-381
17. Pacheco-Rodriguez G., Kumaki F., Steagall W.K., et al. Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene. J Immunol 182 (2009) 1270-1277
18. Ryu J.H., Moss J., Beck G.J., et al. The NHLBI Lymphangioleiomyomatosis Registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med 173 (2006) 105-111
19. Odajima N., Betsuyaku T., Nasuhara Y., and Nishimura M. Loss of caveolin-1 in bronchiolization in lung fibrosis. J Histochem Cytochem 55 (2007) 899-909
20. Betsuyaku T., Griffin G.L., Watson M.A., and Robert Sr. M. Laser capture microdissection and real-time reverse transcriptase/polymerase chain reaction of bronchiolar epithelium after bleomycin. Am J Respir Cell Mol Biol 25 (2001) 278-284
21. Fuke S., Betsuyaku T., Nasuhara Y., Morikawa T., Katoh H., and Nishimura M. Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 31 (2004) 405-412
22. Guo H., Majmudar G., Jensen T.C., Biswas C., Toole B.P., and Gordon M.K. Characterization of the gene for human EMMPRIN, a tumor cell surface inducer of matrix metalloproteinases. Gene 220 (1998) 99-108
23. Betsuyaku T., Nishimura M., Takeyabu K., et al. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med 159 (1999) 1985-1991
24. Betsuyaku T., Kadomatsu K., Griffin G.L., Muramatsu T., and Senior R.M. Increased basigin in bleomycin-induced lung injury. Am J Respir Cell Mol Biol 28 (2003) 600-606
25. Hakuma N., Betsuyaku T., Kinoshita I., et al. High incidence of extracellular matrix metalloproteinase inducer (EMMPRIN) expression in non-small cell lung cancers: association with clinicopathological parameters. Oncology 72 (2007) 197-204
26. Koga K., Nabeshima K., Aoki M., et al. Emmprin in epitheliod sarcoma: expression in tumor cell membrane and stimulation of MMP-2 production in tumor-associated fibroblasts. Int J Cancer 120 (2006) 761-768
27. Krymskaya V.P. Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis. Proc Am Thorac Soc 5 (2008) 119-126
28. Gabison E.E., Hoang-Xuan T., Mauviel A., and Menashi S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 87 (2005) 361-368
29. Tang W., Chang S.B., and Hemler M.E. Links between CD147 function, glycosylation, and caveolin-1. Mol Biol Cell 15 (2004) 4043-4050
30. Hosokawa T., Betsuyaku T., Odajima N., et al. Role of basement membrane in EMMPRIN/CD147 induction in rat tracheal epithelial cells. Biochem Biophys Res Commun 368 (2008) 426-432
31. Szymanowska M., Hendry K.A., Robinson C., and Kolb A.F. EMMPRIN (basigin/CD147) expression is not correlated with MMP activity during adult mouse mammary gland development. J Cell Biochem 106 (2009) 52-62
32. Tang Y., Kesavan P., Nakada M.T., and Yan L. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res 2 (2004) 73-80
33. Sidhu S.S., Mengistab A.T., Tauscher A.N., LaVail J., and Basbaum C. The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene 23 (2004) 956-963
34. Gabison E.E., Mourah S., Steinfels E., et al. Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction. Am J Pathol 166 (2005) 209-219
35. Evans S.E., Colby T.V., Ryu J.H., and Limper A.H. Transforming growth factor-beta 1 and extracellular matrix-associated fibronectin expression in pulmonary lymphangioleiomyomatosis. Chest 125 (2004) 1063-1070